Immunic, Inc. (NASDAQ:IMUX) Receives $12.67 Consensus Target Price from Analysts
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are presently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year price objective […]
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are presently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year price objective […]
